Vorinostat (SAHA, MK0683)
-
- 应用范围
- Inhibition Assay (InhA), Functional Studies (Func)
- 原理
- Vorinostat (rINN) or suberoylanilide hydroxamic acid (SAHA), is a drug currently under investigation for the treatment of cutaneous T cell lymphoma (CTCL), a type of skin cancer, to be used when the disease persists, gets worse, or comes back during or after treatment with other medicines. It is the first in a new class of agents known as histone deacetylase inhibitors. A recent study suggested that vorinostat also possesses some activity against recurrent glioblastoma multiforme, resulting in a median overall survival of 5.7 months (compared to 4 - 4.4 months in earlier studies). Further brain tumor trials are planned in which vorinostat will be combined with other drugs.
- 产品特性
-
Tradename: ZOLINZA
Source of Compound: synthetic
Target: HDAC inhibitor
Receptor: HDAC1, HDAC2, HDAC3, HDAC6, HDAC8
- 纯化方法
- All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.
- 纯度
- 98 %
- Formula
- C14H20N2O3
- Solubility
- Soluble in water
-
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 状态
- Solid
- 储存条件
- -20 °C
- 储存方法
-
For the majority of compounds, they could be dissolved in DMSO or other organic solvent.
Their stock solution can be stored at -20°C for up to 3 months and aliquoted for sampling convenience.
Several freeze/thaw cycles should not damage the activity of our small molecule products.
However, in many instances the aqueous solutions of some compounds need to be made fresh and cannot be stored. For these compounds, their solution should be prepared just before use and stored no longer than 24 hours. - 有效期
- 24 months
-
- 背景
- Chromatin/Epigenetic
- 分子量
- 264.32 g/mol
- CAS-编号
- 149647-78-9
-